Sign in

CIK 0001595097

  • Non-accelerated filer
  • Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464348039
Phone
+1 617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale Chief Medical Officer sold 6,393 shares at $6.78 ($43,330)
  3. 4 Planned sale Chief Financial Officer sold 2,792 shares at $8.76 ($24,446)
  4. 4 Planned sale Chief Executive Officer sold 7,134 shares at $8.76 ($62,465)
  5. 4 Grant or award Chief Medical Officer acquired 27,200 shares (grant or award)
  6. 4 Grant or award Chief Financial Officer acquired 27,500 shares (grant or award)
  7. 4 Grant or award Chief Executive Officer acquired 68,100 shares (grant or award)
  8. 4 Open-market buy 10% owner bought 350,000 shares at an average $20.01 ($7,003,761)
  9. 4 Grant or award Director acquired 5,566 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Planned sale Chief Financial Officer sold 18,043 shares at an average $47.88 ($863,838)
  12. 4 Planned sale Chief Executive Officer sold 63,358 shares at an average $46.57 ($2,950,518)
  13. 4 Exercise or conversion Director acquired 1,667 shares (option exercise)
  14. 4 Grant or award Director acquired 2,783 shares (grant or award)
  15. 4 Grant or award Director acquired 2,783 shares (grant or award)
  16. 4 Grant or award Director acquired 2,783 shares (grant or award)
  17. 4 Grant or award Director acquired 2,783 shares (grant or award)
  18. 4 Grant or award Director acquired 2,783 shares (grant or award)
  19. 4 Grant or award Director acquired 2,783 shares (grant or award)
  20. 4 Grant or award Director acquired 2,783 shares (grant or award)

Page 3 of 17 · 340 filings